Increased activation-induced cell death in peripheral lymphocytes of rheumatoid arthritis patients: The mechanism of action

Immunology

Volumn 112, Issue 3, 2004, Pages 496-505

  Tang, Xiaolei ^a   Yocum, David E ^a   Dejonghe, David ^a   Nordensson, Kathryn ^a   Lake, Douglas F ^a   Richard, John ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Autoimmunity: rheumatoid arthritis; CD14+ cells; Human; Lymphocytes: autoreactive; T cells

Indexed keywords

CD14 ANTIGEN; CD3 ANTIGEN; PHYTOHEMAGGLUTININ;

ADULT; ARTICLE; CELL ACTIVATION; CELL CULTURE; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SUPERNATANT;

ADULT; ANTIGENS, CD14; ARTHRITIS, RHEUMATOID; AUTOANTIGENS; CASE-CONTROL STUDIES; CELL DEATH; CELLS, CULTURED; HUMANS; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTES; MIDDLE AGED; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES;

EID: 3042789082     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2004.01888.x     Document Type: Article

References (66)

1. Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet 2001; 358:903-11.
2. VanderBorght A, Geusens P, Raus J, Stinissen P. The autoimmune pathogenesis of rheumatoid arthritis: role of autoreactive T cells and new immunotherapies. Semin Arthritis Rheum 2001; 31:160-75.
3. Panayi GS, Corrigall VM, Pitzalis C. Pathogenesis of rheumatoid arthritis. The role of T cells and other beasts. Rheum Dis Clin North Am 2001; 27:317-34.
4. Weyand CM. New insights into the pathogenesis of rheumatoid arthritis. Rheumatology 2000; 39 (Suppl. 1):3-8.
5. Yocum DE. T cells: pathogenic cells and therapeutic targets in rheumatoid arthritis. Semin Arthritis Rheum 1999; 29:27-35.
6. Gause A, Berek C. Role of B cells in the pathogenesis of rheumatoid arthritis: potential implications for treatment. Biodrugs 2001; 15:73-9.
7. Zhang Z, Bridges SL Jr. Pathogenesis of rheumatoid arthritis. Role of B lymphocytes. Rheum Dis Clin North Am 2001; 27:335-53.
8. Perlman H, Pagliari LJ, Liu H, Koch AE, Haines GK 3rd., Pope RM. Rheumatoid arthritis synovial macrophages express the Fas-associated death domain-like interleukin-1 beta-converting enzyme-inhibitory protein and are refractory to Fas-mediated apoptosis. Arthritis Rheum 2001; 44:21-30.
9. Thomas R, MacDonald KP, Pettit AR, Cavanagh LL, Padmanabha J, Zehntner S. Dendritic cells and the pathogenesis of rheumatoid arthritis. J Leukoc Biol 1999; 66:286-92.
10. Yamanishi Y, Firestein GS. Pathogenesis of rheumatoid arthritis, the role of synoviocytes. Rheum Dis Clin North Am 2001; 27:355-71.
11. Pap T, Muller-Ladner U, Gay RE, Gay S. Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res 2000; 2:361-7.
12. Szekanecz Z, Koch AE. Cell-cell interactions in synovitis. Endothelial cells and immune cell migration. Arthritis Res 2000; 2:368-73.
13. Verheijden GF, Rijnders AW, Bos E et al. Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis. Arthritis Rheum 1997; 40:1115-25.
14. Krco CJ, Watanabe S, Harders J, Griffths MM, Luthra H, David CS. Identification of T cell determinants on human type II collagen recognized by HLA-DQ8 and HLA-DQ6 transgenic mice. J Immunol 1999; 163:1661-5.
15. Snijders A, Elferink DG, Geluk A et al. An HLA-DRB1-derived peptide associated with protection against rheumatoid arthritis is naturally processed by human APCs. J Immunol 2001; 166:4987-93.
16. Tosato G, Steinberg AD, Blaese RM. Defective EBV-specific suppressor T-cell function in rheumatoid arthritis. N Engl J Med 1981; 305:1238-43.
17. Griffiths MM, Wang J, Joe B et al. Identification of four new quantitative trait loci regulating arthritis severity and one new quantitative trait locus regulating autoantibody production in rats with collagen-induced arthritis. Arthritis Rheum 2000; 43:1278-89.
18. Kohsaka H, Nanki T, Ollier WE, Miyasaka N, Carson DA. Influence of the rheumatoid arthritis-associated shared epitope on T-cell receptor repertoire formation. Proc Assoc Am Phys 1996; 108:323-8.
19. Taams LS, Wauben MH. Anergic T cells as active regulators of the immune response. Hum Immunol 2000; 61:633-9.
20. Lenardo M, Chan FK-M, Hornung F et al. Mature T lymphocyte apoptosis - immune regulation in a dynamic and unpredictable antigenic environment. Annu Rev Immunol 1999; 42:221-53.
21. Mauri C, Chu CQ, Woodrow D, Mori L, Londei M. Treatment of a newly established transgenic model of chronic arthritis with nondepleting anti-CD4 monoclonal antibody. J Immunol 1997; 159:5032-41.
22. Choy EH, Kingsley GH, Panayi GS. Innovative treatment approaches for rheumatoid arthritis. T-cell regulation. Baillieres Clin Rheumatol 1995; 9:653-71.
23. Wells AD, Li XC, Li Y et al. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nat Med 1999; 5:1303-7.
24. Van Parijs L, Ibraghimov A, Abbas AK. The roles of co-stimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity 1996; 4:321-8.
25. Van Parijs L, Abbas AK. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science 1998; 280:243-8.
26. Zhang J, Bardos T, Mikecz K, Finnegan A, Glant TT. Impaired Fas signaling pathway is involved in defective T cell apoptosis in autoimmune murine arthritis. J Immunol 2001; 166:4981-6.
27. Okazaki H, Sato H, Kamimura T et al. In vitro and in vivo inhibition of activation induced T cell apoptosis by bucillamine. J Rheumatol 2000; 27:1358-64.
28. Salmon M, Scheel-Toellner D, Huissoon AP et al. Inhibition of T cell apoptosis in the rheumatoid synovium. J Clin Invest 1997; 99:439-46.
29. Wakisaka S, Suzuki N, Takeba Y et al. Modulation by proinflammatory cytokines of Fas/Fas ligand-mediated apoptotic cell death of synovial cells in patients with rheumatoid arthritis (RA). Clin Exp Immunol 1998; 114:119-28.
30. Hasunuma T, Hoa TT, Aono H et al. Induction of Fas-dependent apoptosis in synovial infiltrating cells in rheumatoid arthritis. Int Immunol 1996; 8:1595-602.
31. Lorenz HM, Grunke M, Hieronymus T et al. In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases. Arthritis Rheum 1997; 40:306-17.
32. Schirmer M, Vallejo AN, Weyand CM, Goronzy JJ. Resistance to apoptosis and elevated expression of Bcl-2 in clonally expanded CD4+ CD28- T cells from rheumatoid arthritis patients. J Immunol 1998; 161:1018-25.
33. Tang X, Yocum DE, DeJonghe D, Nordensson K. Characterizing a soluble survival signal for activated lymphocytes from CD14+ cells. Immunology 2002; 107:56-68.
34. Boyum A. Separation of leukocytes from blood and bone marrow. Introduction. Scand J Clin Lab Invest Suppl 1968; 97:7.
35. Klasen IS, Kool J, Melief MJ et al. Arthritis by autoreactive T cell lines obtained from rats after injection of intestinal bacterial cell wall fragments. Cell Immunol 1992; 139:455-67.
36. Yoshino S, Cleland LG, Mayrhofer G. Treatment of collagen-induced arthritis in rats with a monoclonal antibody against the alpha/beta T cell antigen receptor. Arthritis Rheum 1991; 34:1039-47.
37. Goldschmidt TJ, Holmdahl R. Anti-T cell receptor antibody treatment of rats with established autologous collagen-induced arthritis: suppression of arthritis without reduction of anti-type II collagen autoantibody levels. Eur J Immunol 1991; 21:1327-30.
38. Yoshino S, Schlipkoter E, Kinne R, Hunig T, Emmrich F. Suppression and prevention of adjuvant arthritis in rats by a monoclonal antibody to the alpha/beta T cell receptor. Eur J Immunol 1990; 20:2805-8.
39. Ridge SC, Zabriske JB, Oronsky AL, Kerwar SS. Streptococcal cell wall arthritis: studies with nude (athymic) inbred Lewis rats. Cell Immunol 1985; 96:231-4.
40. Holoshitz J, Matitiau A, Cohen IR. Role of the thymus in induction and transfer of vaccination against adjuvant arthritis with a T lymphocyte line in rats. J Clin Invest 1985; 75:472-7.
41. Kakimoto K, Katsuki M, Hirofuji T, Iwata H, Koga T. Isolation of T cell line capable of protecting mice against collagen-induced arthritis. J Immunol 1988; 140:78-83.
42. Murata H, Yata J. Defect of suppressor cell induction in patients with juvenile rheumatoid arthritis. Asian Pac J Allergy Immunol 1986; 4:95-9.
43. Binderup L. Decreased T-suppressor cell activity in rats with adjuvant arthritis. Ann Rheum Dis 1983; 42:693-8.
44. Kayashima K, Koga T, Onoue K. Role of T lymphocytes in adjuvant arthritis. II. Different subpopulations of T lymphocytes functioning in the development of the disease. J Immunol 1978; 120:1127-31.
45. Kayashima K, Koga T, Onoue K. Role of T lymphocytes in adjuvant arthritis. I. Evidence for the regulatory function of thymus-derived cells in the induction of the disease. J Immunol 1976; 117(5 Part 2):1878-82.
46. VanderBorght A, Geusens P, Vandevyver C, Raus J, Stinissen P. Skewed T-cell receptor variable gene usage in the synovium of early and chronic rheumatoid arthritis patients and persistence of clonally expanded T cells in a chronic patient. Rheumatology (Oxford) 2000; 39:1189-201.
47. Hall FC, Thomson K, Procter J, McMichael AJ, Wordsworth BP. TCR beta spectratyping in RA. evidence of clonal expansions in peripheral blood lymphocytes. Ann Rheum Dis 1998; 57:319-22.
48. Martens PB, Goronzy JJ, Schaid D, Weyand CM. Expansion of unusual CD4+ T cells in severe rheumatoid arthritis. Arthritis Rheum 1997; 40:1106-14.
49. Celis L, Vandevyver C, Geusens P, Dequeker J, Raus J, Zhang J. Clonal expansion of mycobacterial heat-shock protein-reactive T lymphocytes in the synovial fluid and blood of rheumatoid arthritis patients. Arthritis Rheum 1997; 40:510-19.
50. Alam A, Lambert N, Lule J et al. Persistence of dominant T cell clones in synovial tissues during rheumatoid arthritis. J Immunol 1996; 156:3480-5.
51. Thompson SD, Grom AA, Bailey S et al. Patterns of T lymphocyte clonal expansion in HLA-typed patients with juvenile rheumatoid arthritis. J Rheumatol 1995; 22:1356-64.
52. Fitzgerald JE, Ricalton NS, Meyer AC et al. Analysis of clonal CD8+ T cell expansions in normal individuals and patients with rheumatoid arthritis. J Immunol 1995; 154:3538-47.
53. Goronzy JJ, Bartz-Bazzanella P, Hu W, Jendro MC, Walser-Kuntz DR, Weyand CM. Dominant clonotypes in the repertoire of peripheral CD4+ T cells in rheumatoid arthritis. J Clin Invest 1994; 94:2068-76.
54. DerSimonian H, Sugita M, Glass DN et al. Clonal V, alpha 12.1+ T cell expansions in the peripheral blood of rheumatoid arthritis patients. J Exp Med 1993; 177:1623-31.
55. Sekine T, Kato T, Masuko-Hongo K et al. Type II collagen is a target antigen of clonally expanded T cells in the synovium of patients with rheumatoid arthritis. Ann Rheum Dis 1999; 58:446-50.
56. Schmidt D, Goronzy JJ, Weyand CM. CD4+ CD7- CD28-T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Invest 1996; 97:2027-37.
57. Maeda T, Yamada H, Nagamine R et al. Involvement of CD4+, CD57+ T cells in the disease activity of rheumatoid arthritis. Arthritis Rheum 2002; 46:379-84.
58. Rittner HL, Zettl A, Jendro MC, Bartz-Bazzanella P, Goronzy JJ, Weyand CM. Multiple mechanisms support oligoclonal T cell expansion in rheumatoid synovitis. Mol Med 1997; 3:452-65.
59. Kohem CL, Brezinschek RI, Wisbey H, Tortorella C, Lipsky PE, Oppenheimer-Marks N. Enrichment of differentiated CD45RBdim, CD27- memory T cells in the peripheral blood, synovial fluid, and synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum 1996; 39:844-54.
60. Thomas R, McIlraith M, Davis LS, Lipsky PE. Rheumatoid synovium is enriched in CD45RBdim mature memory T cells that are potent helpers for B cell differentiation. Arthritis Rheum 1992; 35:1455-65.
61. Perlman H, Pagliari LJ, Georganas C, Mano T, Walsh K, Pope RM. FLICE-inhibitory protein expression during macrophage differentiation confers resistance to fas-mediated apoptosis. J Exp Med 1999; 190:1679-88.
62. Jan M, Herbert S. Expression of soluble CD137 correlates with activation-induced cell death of lymphocytes. Cytokine 2000; 12:742-6.
63. Lenardo MJ. Interleukin-2 programs mouse αβ T lymphocytes for apoptosis. Nature 1991; 353:858-61.
64. Nieto MA, Gonzalez A, Lopez-Rivas A, Diaz-Espada F, Gambon F. IL-2 protects against anti-CD3-induced cell death in human medullary thymocytes. J Immunol 1990; 145:1364-8.
65. Schmitz I, Krueger A, Baumann S, Schulze-Bergkamen H, Krammer PH, Kirchhoff S. An IL-2-dependent switch between CD95 signaling pathways sensitizes primary human T cells toward CD95-mediated activation-induced cell death. J Immunol 2003; 171:2930-6.
66. Zhang J, Bardos T, Shao Q, Tschopp J, Mikecz K, Glant TT, Finnegan A. IL-4 potentiates activated T cell apoptosis via an IL-2-dependent mechanism. J Immunol 2003; 170:3495-503.